Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.
Press releases published on April 25, 2025
The Salvation Army Announces Return of ‘Fly the Flag’ Program to Provide Support to Local Residents in Need
EIN Presswire
·
April 25, 2025
Volunteers and Community Partners from The Salvation Army Milford Corps will install 500 American flags throughout Milford, Hopedale, and Mendon MILFORD, MA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- The American flag is a timeless symbol of …
inSegment Celebrates 18 Years of Growth
EIN Presswire
·
April 25, 2025
BOSTON, MA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- inSegment, a leading full-service digital marketing and advertising agency, celebrates eighteen years of helping clients achieve quantifiable, high-impact marketing results. April 25th, …
United Planet Names Jade Ho as 2025 United Planet Fellow
EIN Presswire
·
April 25, 2025
Jade Ho named 2025 United Planet Fellow, continuing her journey of global service and cross-cultural leadership with the Boston-based nonprofit. BOSTON, MA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- United Planet is proud to announce the …
Biological roles for three strand DNA and RNA flipon structures
EIN Presswire
·
April 25, 2025
The cell's version of the multiverse! Here, the focus is on three-stranded DNA and RNA triplex structures. Their biological relevance is now coming into focus. CHARLESTOWN, MA, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- A paper released on …
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
GlobeNewswire
·
April 25, 2025
Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co- …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …
Harbinger Health Unveils Promising New Data on Early Cancer Detection Platform at AACR 2025
GlobeNewswire
·
April 25, 2025
Novel analytical framework establishes a clinically meaningful performance assessment of blood-based early detection tests Innovative methodology enhances cancer signal detection, boosts specificity and predictive value Presentations further validate the …
ReversingLabs Delivers Most Comprehensive Support for CycloneDX xBOM
GlobeNewswire
·
April 25, 2025
CAMBRIDGE, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- ReversingLabs (RL), the trusted name in file and software security, today announced the launch of leading support for eXtended Bill of Materials (xBOM) capabilities with Spectra Assure™. Available now, …
Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025
GlobeNewswire
·
April 25, 2025
BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the …
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
GlobeNewswire
·
April 25, 2025
WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …
Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
Presentation to highlight how AP3 Generative Phosphoproteomic analyses uncover how ACR-2316 induces mitotic and replicative tumor cell death, and the mechanisms underlying its superior potency observed preclinically Phase 1 trial of ACR-2316 ahead of …
BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference
GlobeNewswire
·
April 25, 2025
BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …